Key facts
- This page summarizes Ted D. Kellner's Form 3 filing for AIM ImmunoTech Inc. (AIMI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2024, 15:23.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents shares held by the Kellner, Mary T Kellner Revocable Trust, for which the reporting person serves as co-trustee with his spouse.
Footnote F2
Represents shares held by the Beta Fund Investment Club, for which the reporting person serves as manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Footnote F3
Represents shares held by the Kellner, Jack F Desc Trust FBO Ted D. Kellner, for which the reporting person serves as trustee.
Footnote F4
Represents shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.
Footnote F5
Represents shares held by the Kellner GRAT, a grantor retained annuity trust, for which the reporting person's spouse serves as trustee.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney